Literature DB >> 9116557

Primary care--opportunities and threats. Developing prescribing in primary care.

C P Bradley1, R J Taylor, A Blenkinsopp.   

Abstract

The latest white papers on the NHS focus on stimulating innovation in the delivery of primary care and removing barriers to further development. Some of this innovation relates directly to prescribing in primary care, and in this article the authors speculate on what might happen if the prescribing initiatives referred to in the white papers were extended and disseminated more widely. The initiatives which might have the biggest impact are those encouraging closer collaboration between general practitioners and community pharmacists and those aiding extension of the current nurse prescribing scheme in primary care. Both offer considerable opportunities to improve primary care, but both bear some potential risks.

Mesh:

Year:  1997        PMID: 9116557      PMCID: PMC2126153          DOI: 10.1136/bmj.314.7082.744

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  9 in total

Review 1.  Prescription data as a tool in pharmacotherapy audit (II). The development of an instrument.

Authors:  C S de Vries; P B van den Berg; J W Timmer; A Reicher; W Blijleven; T F Tromp; L T de Jong-van den Berg
Journal:  Pharm World Sci       Date:  1999-04

2.  Partnerships or power struggles? The 'Crown' review of prescribing.

Authors:  R J Taylor
Journal:  Br J Gen Pract       Date:  1999-05       Impact factor: 5.386

3.  Clinical governance--a new label for old ingredients: quality or quantity?

Authors:  L F Smith; D Harris
Journal:  Br J Gen Pract       Date:  1999-05       Impact factor: 5.386

4.  Perceived interprofessional barriers between community pharmacists and general practitioners: a qualitative assessment.

Authors:  Carmel M Hughes; Siobhan McCann
Journal:  Br J Gen Pract       Date:  2003-08       Impact factor: 5.386

5.  Pharmaceutical care and its relationship to prescribing behaviour of general practitioners.

Authors:  Paul E M Muijrers; Richard P T M Grol; Jildou Sijbrandij; Rob Janknegt; J André Knottnerus
Journal:  Pharm World Sci       Date:  2006-11-17

6.  Prescribing indicators. Development and validation of guideline-based prescribing indicators as an instrument to measure the variation in the prescribing behaviour of general practitioners.

Authors:  Paul E M Muijrers; Rob Janknegt; Jildou Sijbrandij; Richard P T M Grol; J André Knottnerus
Journal:  Eur J Clin Pharmacol       Date:  2004-10-26       Impact factor: 2.953

Review 7.  Over-the-counter analgesics in older adults: a call for improved labelling and consumer education.

Authors:  Christianne L Roumie; Marie R Griffin
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

Review 8.  Changing prescribing in the light of tolerability concerns: how is this best achieved?

Authors:  C S de Vries; C A Duggan; T F Tromp; L T de Jong-van den Berg
Journal:  Drug Saf       Date:  1999-09       Impact factor: 5.228

9.  Pattern of drug therapy problems and interventions in ambulatory patients receiving antiretroviral therapy in Nigeria.

Authors:  Victor B Ojeh; Nasir Naima; Isaac O Abah; Kakjing D Falang; Ogwuche Lucy; Ibrahim London; Christiana Dady; Patricia Agaba; Oche Agbaji
Journal:  Pharm Pract (Granada)       Date:  2015-06-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.